Effects of Essential Amino Acid-enriched Whey and Carbohydrate Co-ingestion on Protein Kinetics
Determining Optimal Energy Substrate to Enhance Postprandial Protein Kinetic Responses to Essential Amino Acid-enriched Whey During Energy Deficit
1 other identifier
interventional
17
1 country
1
Brief Summary
Previous work conducted by the Investigators demonstrates that an essential amino acid(EAA)-enriched whey protein combination format is an efficient EAA/protein format to support enhanced whole-body protein balance and sustain muscle protein synthesis compared to isonitrogenous amounts of whey alone or a mixed-macronutrient meal. However, additional work is needed to optimize the formulation to ensure the best possible muscle and whole-body anabolic responses are achieved. This includes addressing the potential value of adding non-EAA/protein components to support energy demands. Providing additional non-protein energy to an EAA-enriched whey protein formulation may reduce the proportion of exogenous amino acids directed towards energy production thereby preserving its use for muscle protein synthesis. However, whether suppressing exogenous amino acid oxidation by providing additional carbohydrate allows for a greater muscle protein synthetic stimulus during moderate energy deficit (- 30% total energy requirements) is unknown. Therefore, this study will test the effects of EAA-enriched whey protein plus carbohydrate versus EAA-enriched whey plus additional EAA using a randomized, cross-sectional longitudinal study design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2020
CompletedStudy Start
First participant enrolled
September 9, 2020
CompletedFirst Posted
Study publicly available on registry
November 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 23, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 23, 2022
CompletedJanuary 27, 2025
October 1, 2022
2 years
August 24, 2020
January 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Whole-body Protein Balance
Whole-body net balance will be determined using stable-isotope methodologies
approximately 5.75 hours
Whole-body Protein Synthesis
Whole-body protein synthesis will be determined using stable-isotope methodologies
approximately 5.75 hours
Whole-body Protein Breakdown
Whole-body protein breakdown will be determined using stable-isotope methodologies
approximately 5.75 hours
Muscle Protein Synthesis
Muscle protein synthesis will be determined using stable-isotope methodologies
approximately 5.75 hours
Study Arms (4)
EAA+W & Carbohydrate: Balance (BAL) first, then Deficit (DEF)
ACTIVE COMPARATORParticipants will consume an essential amino acid plus whey (EAA+W) beverage with added Carbohydrate during energy balance (BAL) first, then again during energy deficit (DEF).
EAA+W & Carbohydrate: DEF first, then BAL
ACTIVE COMPARATORParticipants will consume an essential amino acid plus whey beverage with added Carbohydrate during energy deficit first, then again during energy balance.
EAA+W & EAA: BAL first, then DEF
ACTIVE COMPARATORParticipants will consume an essential amino acid (EAA) plus whey beverage with added EAA during energy balance first, then again during energy deficit.
EAA+W & EAA: DEF first, then BAL
ACTIVE COMPARATORParticipants will consume an essential amino acid (EAA) plus whey beverage with added EAA during energy deficit first, then again during energy balance.
Interventions
Essential amino acid plus whey beverage with added carbohydrate
Essential amino acid plus whey beverage with added essential amino acid
Eligibility Criteria
You may qualify if:
- Body mass index \< 30.0 kg/m2
- Weight stable in the past 2 months (± 2.27 kg)
- Healthy without evidence of chronic illness or musculoskeletal injury as determined by the USARIEM Office of Medical Support and Oversight (OMSO) or home duty station medical support
- Functional exercise (i.e., step ups, box jumps, body mass movements) and/or aerobic exercise trained defined by self-report as performing ≥ 2 sessions/wk for previous 6 months
- Willing to refrain from taking any nonsteroidal anti-inflammatory drugs (e.g., aspirin, Advil®, Aleve®, Naprosyn®), or any other aspirin-containing product for 10 days before the first \~8.5 hour laboratory day and at least 5 days after completing the last \~8.5 hour laboratory day
- Willing to refrain from alcohol, smoking any nicotine product (includes e-cigarettes), vaping, chewing tobacco, caffeine, and dietary supplements after the completing the baseline period until the end of the study
- Must obtain supervisor approval for federal civilian employees and non-HRV active duty military personnel working within the US Army Natick Soldier Systems Center
- Females must have normal menstrual cycles between 26-32 days in duration; 5 menstrual cycles within the past 6 months; or able to provide documentation of oral/hormonal contraceptive use which contains low-dose estrogen/progesterone to maintain continuous levels throughout the 28-day cycle (i.e., no placebos)
You may not qualify if:
- Metabolic or cardiovascular abnormalities, gastrointestinal disorders (e.g., kidney disease, diabetes, cardiovascular disease, etc.)
- Abnormal PT/PTT test or problems with blood clotting
- History of complications with lidocaine
- Present condition of alcoholism, anabolic steroids, or other substance abuse issues as assessed by OMSO
- Participation in blood donation within 8-wk of beginning the study
- Pregnant, trying to become pregnant, and/or breastfeeding (results of urine pregnancy test or self-report for breastfeeding will be obtained before body composition testing)
- Unwillingness or inability to consume study diets or foods provided due to personal preference, dietary restrictions, and/or food allergies
- Unwillingness to adhere to study physical restrictions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- United States Army Research Institute of Environmental Medicinelead
- University of Arkansascollaborator
- Eastern Michigan Universitycollaborator
Study Sites (1)
US Army Research Institute of Environmental Medicine
Natick, Massachusetts, 01760, United States
Related Publications (2)
Gwin JA, Robillard JT, Murphy NE, Carrigan CT, Wilson MA, Varanoske AN, Church DD, Ferrando AA, Pasiakos SM, Margolis LM. Elevated miR-194-5p Expression During Short-term Energy Deficit Attenuates Post-Exercise Muscle Protein Synthesis by Inhibiting Anabolic Signaling. J Nutr. 2026 Jan 27:101380. doi: 10.1016/j.tjnut.2026.101380. Online ahead of print.
PMID: 41611130DERIVEDGwin JA, Church DD, Allen JT, Wilson MA, Carrigan CT, Murphy NE, Varanoske AN, Margolis LM, Wolfe RR, Ferrando AA, Pasiakos SM. Consuming Whey Protein with Added Essential Amino Acids, Not Carbohydrate, Maintains Postexercise Anabolism While Underfed. Med Sci Sports Exerc. 2025 Jan 1;57(1):70-80. doi: 10.1249/MSS.0000000000003541. Epub 2024 Aug 23.
PMID: 39160756DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jess A Gwin, PhD
US Army Research Institute of Environmental Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- double (participant and investigator)
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2020
First Posted
November 9, 2020
Study Start
September 9, 2020
Primary Completion
August 23, 2022
Study Completion
August 23, 2022
Last Updated
January 27, 2025
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share